Skip to content

Clinical trials

Phase 3 Immune System Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Phase: Phase 3 Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20151
20162
20171
20182
20221
20233
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Terminated3
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Takeda2
Adienne SA1
Ariad Pharmaceuticals1
Baxalta now part of Shire1
Biogen1
Bristol-Myers Squibb1
Eli Lilly and Company1
La Jolla Pharmaceutical Company1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases15
Autoimmune Diseases8
Connective Tissue Diseases5
Lupus Erythematosus, Systemic5
Hematologic Diseases3
Hypersensitivity3
Asthma2
Blood Platelet Disorders2
Bronchial Diseases2
Cytopenia2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.